NHS, Alzheimer's

NHS will not fund new drug to slow Alzheimer’s
A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS in England, the drugs spending watchdog says. Donanemab was hailed as a turning point in the disease last year. But the National Institute ...
Eli Lilly’s Alzheimer’s drug donanemab rejected for NHS use
Alzheimer’s drug donanemab for use in the country's national health service (NHS). The National Institute for Health and Care Excellence (NICE), which sets drug policy for the NHS, issued a draft guidance on Wednesday,
New Alzheimer’s drugs should be available on NHS, says patient’s wife
A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like him will be able to access treatments. New disease-modifying Alzheimer’s drugs work best when they are given to patients in the early stages of disease.
Eli Lilly Alzheimer’s Drug Rejected for NHS Use in England
Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the drug cost regulator deemed its benefits were too small to justify the price.
Live news: Second Alzheimer’s drug deemed too expensive for UK’s NHS
A second Alzheimer’s drug has been rejected as too expensive by the UK’s healthcare spending watchdog despite being approved as safe and effective by the country’s medicines regulator. The decision by the National Institute for Health and Care Excellence to reject Eli Lilly’s donanemab came two months after it similarly ruled that lecanemab,
Alzheimer’s wonder drug faces NHS block over cost
The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare the new treatment for the disease safe for use but the rationing body for the health service will immediately rule that it is too expensive for NHS patients.
'Incredibly disappointing': Pioneering Alzheimer’s drug blocked for widespread NHS use in England
A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”. The news comes as the UK’s medicines regulator said donanemab could be licensed for use in the UK.
Alzheimer's £600k wonder drug to be blocked by NHS over cost despite major breakthrough
Donanemab has been hailed as 'game changer' but it's likely the price tag will bar it from being available to nearly one million Brits.
FM pushes for significant NHS cash boost in budget
The first minister of Wales has pushed for a "significant" boost to NHS finances to be announce in the UK government's Autumn ...
NHS warning as bedtime symptom could be sign of kidney cancer
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
The Harvard Crimson10h
Decades-Long NHS Research Jeopardized by Funding Cuts
The NHS is one of the largest studies of women’s risk factors for major chronic diseases. Initially designed to study the ...
NHS care can be a ‘death sentence’ for some patients – Wes Streeting
NHS care can be a “death sentence” for some patients, the Health Secretary has said as the Prime Minister called for better ...
What the changes to the new NHS app could mean for you
Every NHS patient will carry their medical records with them in a ‘patient passport’ in the NHS app under new plans unveiled ...
Welsh Government's plan to tackle the longest waits on the NHS
The cabinet secretary for health and social care has announced £28m in funding to tackle the longest waits on the NHS ...
The Mirror3d
NHS doctor reveals how to 'get rid of colds quickly' using simple health hack
She said: "I'm an NHS GP and I'm going to give you guys one small, extremely easy tip that's going to reduce the duration and severity of any cold you have this winter. Nutritionist says one drink ...
North West learning disabilities service could become blueprint to save billions for the NHS
Radcliffe Place is the UK's only residential assessment unit which supports young people aged 16 to 25 with learning ...
NHS patients more willing to miss hospital appointments than hairdresser’s, research reveals
NHS patients are more willing to miss hospital appointments than the hairdresser or personal training sessions, a new survey ...